The von Bezold-Jarisch reflex (BJR) is a vagally-mediated chemoreflex from the heart and lungs, causing hypopnea, bradycardia and inhibition of sympathetic vasomotor tone. Cardiac sympathetic nerve activity (CSNA) has not been systematically compared with vasomotor activity during the BJR, however.
Introduction
The von Bezold-Jarisch reflex (BJR) is evoked from cardiopulmonary chemoreceptive afferents, and causes hypopnea, bradycardia and vasodilatation (4, 8, 10, 11, 17) . The cardiovascular actions (bradycardia and systemic vasodilatation) are attributable primarily to activation of unmyelinated vagal afferents (4, 9, 10) with terminals in the left ventricle, which are accessible from the coronary circulation (9, 29) . The BJR may be activated by a variety of chemical stimuli delivered by the circulation to the heart, including veratrum alkaloids (9, 10) , nicotine (12) , and 5HT 3 receptor agonists such as serotonin (42, 44 ) and phenylbiguanide (PBG) (1, 4, 8, 11, 15) . It has been suggested that the BJR is activated by ischemic metabolites during myocardial ischemia and infarction (particularly inferoposterior) and plays a cardioprotective role by reducing the work load of the heart (17, 27, 37).
The reflex vasodilatation of the BJR is due to inhibition of sympathetic vasoconstrictor tone (4, 10) , which is considered to be generalized (43) and has been measured in adrenal (7) , lumbar (35, 44), splanchnic (35), splenic (45) and renal (4, 39, 41, 45 ) sympathetic nerves. With respect to the cardiac sympathetic nerves, the evidence is less clear. A strong parasympathetic bradycardia predominates, and most workers have found that this is essentially abolished by atropine (7, 8, 44) . In some studies however, a component of the bradycardia attributable to sympathetic withdrawal has been inferred from a residual heart rate response after muscarinic blockade (11, 39) , which was then abolished by beta-adrenergic antagonists (2, 49) . Cardiac sympathetic nerve activity (CSNA),
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which has rarely been recorded during the BJR, is reported to be inhibited (1, 38) .
Reflexes may often have discordant actions on cardiac and vasomotor neural drives (24, 34), but no study has yet systematically compared the relative effects of the BJR on cardiac and vascular sympathetic nerves. We set out to establish whether the sympathoinhibition of the BJR was distributed uniformly, or whether this putatively cardioprotective reflex might perhaps inhibit CSNA preferentially. We therefore measured CSNA simultaneously with a representative sympathetic vasomotor outflow (lumbar sympathetic nerve activity: LSNA) and heart rate in anesthetized rats, while the BJR was evoked by PBG delivered intravenously to the right atrium.
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Materials & Methods
Animals
Eighteen adult male Sprague-Dawley rats (320-625g) were used in this study. All procedures conformed to National Health and Medical Research Council guidelines, and were approved by the Animal Experimentation Ethics Committee of the Howard Florey Institute.
Surgical preparation
In all experiments initial anesthesia was induced by pentobarbital sodium (45mg/kg i.p.). Animals were then tracheotomized and artificially ventilated with 2% isoflurane (Rhodia Australia Pty Ltd) in 100% O 2 throughout surgical preparation. Airway pressure was monitored by a transducer attached to the inspiratory line. The right femoral artery and vein were cannulated to measure arterial pressure, and to administer drugs, respectively. The arterial catheter was filled with heparinized saline (20 units/ml) and connected to a pressure transducer. A continuous i.v. infusion of Haemaccel (Hoechst, Melbourne, Australia, 1-2 ml/hr) was given throughout the experiment to help maintain animal's cardiovascular condition (32). Rectal temperature was monitored and maintained between 36.3-37.9 o C with a heating blanket. A catheter was passed down the right jugular vein until its tip lay at the right atrial-vena caval junction for phenylbiguanide (PBG) administration. The bladder was cannulated suprapubically and allowed to drain.
A dorsal incision was made, and a clamp applied to the first thoracic spinal process. This was used to elevate and support the animal's thorax as it lay on its right side for dissection and nerve recording. To expose the left cardiac sympathetic nerves, an incision was made at the base of the scapula, which was freed from underlying muscles and reflected rostrally. The heads of the first three ribs were exposed and the head of the second rib removed with rongeurs. Gentle dissection exposed the cardiac nerve or nerves as they left the stellate ganglion en route for the heart. The most suitable nerve was then cut as close as possible to the pleura. A small pressure foot was positioned below the nerve to reduce cardiac and respiratory displacements. To further reduce movement, a unilateral pneumothorax was made via a lower thoracic intercostal space, and kept patent with a short polyethylene tube. The left lumbar sympathetic trunk was approached retroperitoneally via a flank incision. The trunk was exposed by retraction, cut as distally as convenient (usually between the T5 and T6 ganglia) and dissected free from the surrounding fascia. In seven rats (second experimental series) the vagi were identified in the neck and loosely looped with silk sutures ready for later section.
After completion of surgical procedures, animals were given urethan (1-1.5g/kg i.v. over approximately 30 min) and isoflurane was discontinued.
Nerve recording
Both cardiac and lumbar sympathetic nerve activity was recorded by placing the central cut end of the nerves over silver bipolar hook recording electrodes under pools of mineral oil. The efferent nerve activity was amplified (x 10,000) and filtered (bandpass 10-1000 Hz for LSNA, 300-1000 Hz for CSNA) (Neurolog, Digitimer Ltd, Harlow, UK). The nerve signals were then sent to an oscilloscope, an audio monitor and a computer interface (CED Power1401, CED, Cambridge, UK), along with blood and ventilatory pressures. Signals were recorded for computer analysis using Spike2 software (CED).
Experimental protocol
All experimental protocols were carried out under urethan anesthesia, without any paralyzing agent. In the first experimental series (11 rats), PBG (phenylbiguanide, Sigma, 100Cg/ml) a 5HT 3 receptor agonist, was administered in bolus doses (0.5, 1.0, 1.5 and 2.0Cg) to the right atrium via the jugular cannula to evoke the BJR. Doses were given in ascending order, allowing at least 10 minutes between injections to avoid tachyphylaxis, and the full dose range was repeated three times in each animal. In a second experimental series (7 rats), PBG was given as a single dose (1.5Cg) three times before and after giving methyl atropine (Sigma, 1mg/kg i.v), and again three times after bilateral section of the vagi, allowing at least 10 minutes between injections. At the beginning of the experiment these animals each also received two doses each of phenylephrine (Sigma) and sodium nitroprusside (DBL; 3Cg i.v. in each case) to test nerve responses to raising and lowering blood pressure.
At the end of all experiments, hexamethonium (Aldrich, 50mg/kg, i.v.) was given to demonstrate that recordings were from postganglionic sympathetic fibers and to establish the level of baseline noise. Animals were killed with an overdose of pentobarbital (> 100mg/kg, i.v.). Post mortem examination confirmed that the tip of the jugular cannula was sited within 2 mm of the right atrial inlet in all animals.
Analysis
All analysis was done offline using Spike2 software. Both CSNA and LSNA were rectified, and the respective noise level (measured after hexamethonium) subtracted from each signal. Mean arterial pressure and heart rate were calculated from the blood pressure recording. Records spanning from 30s before (control period) until 30s after each stimulus were extracted for further analysis. For each 1s period in the record, mean rectified CSNA, mean rectified LSNA, mean arterial pressure and the number of heartbeats were calculated.
These data were normalized with respect to their 30s prestimulus control period. 
Statistical analysis
The net response of CSNA, LSNA or heartbeats was defined as its CUSUM value 30s after the stimulus (30s CUSUM). In the first experimental series the significance of differences in net response with respect to neural outflow (CSNA, LSNA or heartbeats), PBG dose and animal was investigated using three-way ANOVA. The significance of pairwise differences between CSNA, LSNA and heartbeat responses was then assessed by the Tukey posthoc test. The inhibitory component of each response was defined as the most negative CUSUM value following the stimulus. This response component was analyzed in the same manner by three-way ANOVA and the Tukey post-hoc test.
The excitatory component of a response (when present) was defined as the difference between the most negative point and the most positive subsequent CUSUM value. These data, however, were not normally distributed, precluding the use of ANOVA. The Wilcoxon signed rank test was therefore used to determine the significance of differences between the excitatory components of CSNA and LSNA to each PBG dose.
To assess the successive effects of methyl atropine and bilateral vagotomy on CSNA, LSNA and heartbeat responses to PBG (in the second experimental series) the 30s CUSUM was calculated for each variable. These 30s CUSUMs were then compared before and after atropine, and before and after vagotomy. For LSNA and heartbeats, 30s CUSUMs were all negative, and the significance of the effects of atropine and vagotomy were compared by paired t-test. In the case of CSNA, 5 animals showed a negative and 2 animals a positive 30s CUSUM. We therefore used the Wilcoxon signed rank test to determine whether the magnitudes of those responses -positive and negativewere shifted towards zero after atropine or vagotomy.
To test for differences in barosensitivity between CSNA and LSNA, the responses of these nerves to phenylephrine and sodium nitroprusside in the same animal were compared by paired t-test.
In all tests, P < 0.05 was considered significant. In the text and illustrations, CUSUM responses to each PBG dose were averaged across animals, and given as mean ± SEM.
Results
Both LSNA and CSNA showed ongoing activity which was strongly modulated by the arterial pulse; inhibited by phenylephrine-induced rises in blood pressure and excited by sodium nitroprusside-induced falls in blood pressure (data not shown). In 5 rats tested, there was no difference between the CSNA and LSNA responses to phenylephrine (-92.5 ± 3.9 % and -83.8 ± 6.5 % of control activity, respectively, for a peak increase in mean arterial pressure of 40.0 ± 3.6 mmHg; P = 0.23) or sodium nitroprusside (+29.8 ± 10.5 % and +34.7 ± 13.0 % above control values, respectively, for a fall in mean arterial pressure of 42.7 ± 5.6 mmHg; P = 0.59).
In experimental series 1, PBG injections to the right atrium caused a doserelated bradycardia and hypotension in all animals (n = 11), confirming published findings (11, 21) . The threshold dose was always 1.0Cg. In response to four PBG doses (0.5, 1.0, 1.5 and 2.0Cg), the maximum falls in heart rate were 61.9 ± 3.0, 197.2 ± 8.6, 282.7 ± 6.9 and 318.0 ± 5.6 bpm, respectively, and the maximum falls in mean arterial pressure were 12 ± 0.8, 30.0 ± 1.1, 40.2 ± 1.2 and 44.5 ± 0.9 mmHg, respectively. Baseline values were 374.3 ± 3.5 bpm and 86.3 ± 1.0 mmHg.
In confirmation of previous reports (35, 44), LSNA was always inhibited by PBG doses above threshold. CSNA, however, gave more variable responses. Two examples, taken from different rats, are illustrated in figure 1. The chart record in figure 1A shows a case where LSNA and CSNA were simultaneously inhibited, to a similar degree. In the case shown in figure 1B, however, CSNA was not inhibited but excited. Inhibition of CSNA followed by excitation was also From the CUSUM measurements, we extracted net responses 30s after the stimulus, maximum inhibitory and excitatory components (see Methods). The net responses of CSNA, LSNA and heartbeats are shown in figure 3 . Three-way ANOVA showed that net responses to PBG were dose-related (P < 0.003) and significantly different between CSNA, LSNA and heartbeats (P < 0.001), and also differed between individual animals (P < 0.001). Post-hoc testing further revealed that the pairwise differences between CSNA, LSNA and heartbeats responses were all significant (P 0.01).
CSNA responses, in particular, were highly variable between animals: in 4 rats of experimental series 1 they were purely excitatory, in 3 others there was early inhibition followed by stronger excitation, while the remaining 4 rats showed predominant inhibition. To further examine the differences between CSNA, LSNA and heartbeat responses, the inhibitory and excitatory components of each variable were separately analyzed (see Methods). Three-way ANOVA applied to the inhibitory component of responses revealed that they were PBG dose-related (P < 0.001) and that there were significant differences between neural responses (CSNA, LSNA, heartbeats; P < 0.001) and between individual rats (P < 0.001).
Post-hoc testing for pairwise differences showed no significant difference between the inhibitory component of CSNA and LSNA responses (P = 0.071), although both differed significantly from the heartbeat response (P < 0.001, for both). Data for the excitatory component failed normality testing and were analyzed non-parametrically. The excitatory components of CSNA and LSNA responses to the two highest PBG doses were significantly different (P < 0.05).
There was no excitatory component in the heartbeat response.
These findings indicate that the differences between the overall BJR responses in CSNA and LSNA are largely attributable to the strength of the excitatory 'rebound', while stronger inhibition distinguished the heartbeat response from that of the two sympathetic nerves. To further investigate the mechanisms underlying the excitatory components of the CSNA and LSNA responses, we performed a second series of experiments on 7 rats. In these, a standard dose of 1.5Cg PBG was administered before and after giving methyl atropine and again after bilateral vagotomy. Figure 4A shows an excitatory CSNA response (seen in 2 rats of this series) and figure 4B an inhibitory CSNA response (seen in 5 rats). Methyl atropine abolished the bradycardic response to PBG (figure 4C, table 1) (P < 0.05). Methyl atropine also significantly reduced the fall in blood pressure after PBG (P < 0.05) but had no significant effect on CSNA and LSNA responses (P > 0.1; P = 0.89, respectively) (figure 4A, B and D; table 1). In the two rats with an excitatory CSNA response to PBG, muscarinic blockade of the vagal bradycardia did not unmask any measurable tachycardia (e.g. figure 4 A and C, which show data from the same animal).
Subsequent bilateral vagotomy substantially reduced the effect of PBG on LSNA (figure 4D, table; P < 0.05). In the case of CSNA, a technical complication arose after vagotomy in 3 rats (one previously excited and two previously inhibited by PBG): vagotomy apparently released a large, transient signal burst in the CSNA recording 2-3s after PBG injection. We remain uncertain how much that burst reflected real CSNA or a signal artifact from elsewhere: it was not associated with any obvious movement, but respiratory pressure and blood pressure were raised for approximately two seconds. Nevertheless, it was clear that bilateral vagotomy significantly attenuated the effects of PBG on CSNA, both excitatory and inhibitory ( figure 4A and B, table 1; P < 0.01).
Discussion
Our null hypothesis was that CSNA should be inhibited at least as much as LSNA, and that heart rate should follow a similar inhibitory profile during activation of the BJR. What we found was quite different, and showed three major points of interest. Firstly, the BJR can excite cardiac sympathetic nerves, in contrast to the widely held belief that this is a uniformly sympathoinhibitory reflex.
Secondly, this cardiac sympathetic nerve excitation occurs in the presence of the well-established vagally-mediated bradycardia (7, 8, 44) , providing evidence that this reflex evokes cardiac sympathovagal co-activation. Lastly, the BJR can produce discordant actions on cardiac and vasomotor sympathetic outflows; increasing the cardiac while decreasing the lumbar sympathetic nerve activity.
Excitatory effects
The frequent excitatory responses that we measured in CSNA during the BJR were a novel and unexpected finding. Whilst CSNA has rarely been directly measured during this reflex (1, 38) , and in these cases was found to be inhibited, it has yet to be compared systematically with a simultaneously recorded sympathetic vasomotor nerve. Excitation of CSNA, however, has been measured during activation of the coronary hypertensive chemoreflex, the "mirror image of the Bezold-Jarisch reflex" (19) in dogs. This reflex may be induced by injection of serotonin into the left atrium or left anterior descending coronary artery (16). It always causes marked hypertension, with variable effects on the heart, attributable to co-activation of vagal and sympathetic cardiac nerves (16).
Tachycardia and hypertension was also seen in response to intracoronary or intravenous PBG in approximately 50% of conscious sheep (40) . The hypertensive reflex contrasts with the classic von Bezold-Jarisch responses reported in the present study, however, where there was always hypotension, sympathetic vasomotor inhibition and bradycardia.
It is worth emphasizing that the net heart rate response to right atrial PBG in our experiments was always bradycardia, notwithstanding any excitatory response in CSNA. This was almost entirely vagal because it was blocked by methyl atropine. This vagal bradycardia (7, 8, 44 ) could have masked cardiac sympathetic effects on heart rate, but we found no supporting data for this. The fact that in the present study one left cardiac sympathetic nerve was cut (for recording) could have contributed to this outcome, although it should be noted that other cardiac nerves on the left and all of those on the right remained intact.
Moreover, in most similar studies where cardiac nerves remained intact, the response was always bradycardia (e.g. (3, 4, 8, 10, 11, 49) ). Measures of cardiac inotropy have also failed to detect any cardioexcitatory response during the BJR (2, 3, 49) , although Barron and Bishop did find a positive inotropic response to intracoronary veratridine which was unmasked after cold block of the cervical vagi (2, 3).
The pattern of response to PBG usually found here for LSNA and CSNA, was that of an initial inhibition followed by a secondary excitatory phase. No secondary phase was apparent in the heart rate response, so by inference, the reflex caused a monotonic excitation of vagal cardioinhibitory neurons. The finding that methyl atropine abolished the reflex bradycardia confirms this view.
Quantitatively, the magnitude of the secondary sympathoexcitatory phase was the main cause of differences between CSNA and LSNA. Possible causes include: 1) concomitant activation by PBG of non-vagal afferents such as cardiac 'sympathetic afferents' (26, 45) or abdominal afferents (14, 45) , which have generally cardiovascular excitatory actions (26, 45) , in contrast to the predominantly sympathoinhibitory actions of vagal afferents (17); 2) unloading of arterial baroreceptors by the fall in blood pressure, which also has sympathoexcitatory consequences (33).
Considering the first of these possible mechanisms, many studies have shown that activation of cardiac "sympathetic" afferents, by electrical stimulation of these afferent fibers (26, 31, 46) or by chemical stimuli such as bradykinin (45, 46), or coronary occlusion (13), has sympathoexcitatory effects. Those excitatory effects may be enhanced or unmasked by vagotomy (14, 31) . With regard to any preferential excitatory action on CSNA, the evidence is limited. Malik and Minisi found that either intracoronary injection of bradykinin or coronary occlusion caused a significantly stronger activation of CSNA than renal SNA in baroreceptor-denervated dogs after bilateral vagotomy (25), and Weaver and coworkers found that epicardially applied bradykinin produced equivalent excitation of splenic and cardiac SNA, which was greater than that of renal SNA (46). Such preferential cardio-cardiac actions could be a consequence of restricted segmental outflow in spinal reflex pathways (36) . In fact, we found that excitatory CSNA responses to PBG were substantially reduced by vagotomy. Thus while 'sympathetic' afferents could have contributed, most of the excitatory component in CSNA seems to be dependent on vagal afferents.
If the second hypothetical mechanism (baroreceptor unloading) were responsible for sympathoexcitation in our experiments, this implies that CSNA responded more strongly to a fall in blood pressure than LSNA. On this point, the literature is inconclusive. Kamiya and colleagues found equivalent excitatory and inhibitory responses of cardiac, renal and muscle SNA to steady state (one minute average) falls and rises in pressure in anesthetized rabbits (20). On the other hand, Ninomiya and colleagues found that CSNA was slightly more strongly inhibited than renal SNA by transient blood pressure rises in conscious cats (28), but did not measure the two nerves' responses to hypotension. When we measured CSNA and LSNA responses to baroreceptor unloading (sodium nitroprusside), we found no material difference between them. This, and our finding that sympathoexcitatory responses to PBG were little changed after methyl atropine, which reduced the hypotension, suggests that baroreceptor unloading was not the primary cause of sympathoexcitatory responses nor could it explain the disparity between CSNA and LSNA responses to PBG.
Sympathovagal Co-activation
Our direct recordings of CSNA at the same time as heart rate revealed that cardiac sympathovagal co-activation was apparently the rule rather than the exception during the BJR. While it could be argued that eliciting the BJR with PBG may cause sympathovagal co-excitation as a consequence of activating more than one afferent type, sympathovagal co-activation has been reported to occur in response to "pure" physiological reflex stimuli. The latter include mild hypoxia and hypercapnia (23) as well as nasopharyngeal afferent stimulation to elicit the diving response (30) . Sympathovagal co-activation has also been suggested to occur during the oculocardiac reflex and in response to somatic noxious stimulation (30) . While its functional significance in the BJR remains uncertain, cardiac sympathovagal co-activation is now recognized as a common centrally-generated autonomic motor pattern, and a series of plausible suggestions about its biological value have been advanced (30) . shows an example from another rat, where CSNA was excited. 
